Published in Sensors (Basel, Switzerland)
Advances in the scientific fields of photogrammetry and computer vision have led to the development of automated multi-image methods that solve the problem of 3D reconstruction. Simultaneously, 3D scanners have become a common source of data acquisition for 3D modeling of real objects/scenes/human bodies. This article presents a comprehensive overv...
Published in Sensors (Basel, Switzerland)
Freeway-diverging areas are prone to low traffic efficiency, congestion, and frequent accidents. Because of the fluctuation of the surrounding traffic flow distribution, the individual decision-making of vehicles in diverging areas is typically unable to plan a departure trajectory that balances safety and efficiency well. Consequently, it is criti...
Published in Frontiers in Medicine
Livedoid vasculopathy (LV) is a thrombo-occlusive vasculopathy that involves the dermal vessels. Clinically, it is characterized by the presence of painful purpuric ulcers on the lower extremities. Histopathologically, it shows intraluminal fibrin deposition and thrombosis, segmental hyalinization, and endothelial proliferation. It is important to ...
Published in Journal of pharmacy practice
Summarize the studies evaluating the use of 4-factor prothrombin complex concentrates in the management of apixaban and rivaroxaban associated intracranial hemorrhages. A PubMed literature search was conducted for articles published between 2013 and 2020 which contained the following terms in their title: (1) apixaban, rivaroxaban, or factor Xa inh...
Published in Drug delivery
Neointimal hyperplasia is a complex process after vascular interventions, acute platelet deposition and smooth muscle cell proliferation both contributed to this process. There are still no perfect solutions to solve this problem. Rivaroxaban is a novel anticoagulant that has been widely used in clinic, it has a good pharmacological effects both in...
Published in The Annals of pharmacotherapy
There are inadequate data on the optimal strategy for transitioning factor Xa inhibitors (FXai; apixaban, rivaroxaban) to unfractionated heparin (UFH) infusions. In patients transitioning from an FXai to an UFH infusion, this study compared the safety and efficacy of monitoring UFH infusions using an activated partial thromboplastin time (aPTT) tit...
Published in The Annals of pharmacotherapy
Rivaroxaban is a first-line option for the management of venous thromboembolism (VTE). However, limited data are available regarding its effectiveness in morbidly obese patients. To evaluate rates of thrombosis and bleeding in morbidly obese patients receiving rivaroxaban or warfarin for VTE. A multicenter, retrospective cohort study was conducted ...
Published in Frontiers in Cardiovascular Medicine
Background Patients with peripheral arterial disease (PAD) are at increased risk for major adverse cardiovascular events (MACE) such as cardiovascular death, myocardial infarction, and stroke as well as major adverse limb events (MALE) such as amputation and acute limb ischemia. Therefore, prevention of thrombotic events is crucial to improve the p...
Published in Frontiers in Pediatrics
Venous thromboembolism is a major hospital acquired complication in the pediatric population over the last two-decades, with a 130% increase in the past decade. Direct oral anticoagulants (DOACs) are a newer class of anticoagulant medication for the treatment and prophylaxis of VTEs that provide the primary advantages of an oral route of administra...
Published in Frontiers in Pharmacology
Background: The role of rivaroxaban in patients with heart failure (HF) combined with left ventricular (LV) thrombus remains unknown in current guideline-directed anticoagulant therapy. The aim of this study was to investigate the impact on clinical outcomes of rivaroxaban compared to vitamin K antagonists (VKAs) in patients with HF combined with L...
